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Introduction
Familial Mediterranean fever (FMF) is a hereditary auto-
inflammatory disease that affects the populations with
certain ethnic backgrounds. It is characterized by self-
limiting febrile attacks of polyserositis. In recent years,
some studies reported that FMF patients had increased
vascular wall alterations and damage which may be
another clinical phenotype of the disease.
Objectives
In the present study, we extensively evaluated biomarkers
related with endothelial damage in regularly treated and
attack-free FMF patients.
Methods
Forty FMF patients and eighteen healthy controls with
no known cardiovascular risk factors were included. All
patients were receiving regular colchicine treatment and
examinations were performed during attack-free periods.
Serum samples were used for the determination of high
sensitive C-reactive protein (hs-CRP), tissue factor (TF),
tissue plasminogen activator (t-PA) and osteoprotegerin
(OPG). Plasma samples were used for the determination
of asymmetric dimethylarginine (ADMA) and thrombo-
modulin (TM).
Results
There were 40 FMF patients (21 M and 19 F, 31 [15-58]
years) and18 healthy subjects (11 M and 7 F, 35.5 [19-46]
years). The median disease duration was 15 (0.6-45)
years. Age, sex distribution, waist circumference, body
mass index, smoking status and serum lipids were similar
between the patients and controls (P > 0.05). The con-
centrations of high sensitive C-reactive protein (hs-CRP)
was significantly higher in FMF patients compared to
controls (hs-CRP: 0.78 [0.03-20.2] vs. 0.15 [0.02-4.71],
µg/ml, P = 0.03). Asymmetric dimethylarginine (ADMA),
osteoprotegerin (OPG) and thrombomodulin (TM) con-
centrations were significantly lower in the patients’ group
compared to those of controls (ADMA: 2.56 [0.84-4.07]
vs. 3.26 [0.88-3.63], umol/l, P = 0.04; OPG: 361.5 [50.5-
1232] vs. 548.9 [193-1181], pg/ml, P = 0.01; TM: 2.69
[0.92-7.26] vs. 3.59 [2.8-8.3], ng/ml, P = 0.001 respec-
tively). However, von Willebrand factor (vWF), tissue
factor (TF) and tissue plasminogen activator (t-PA) levels
were similar between the groups (P > 0.05).
Conclusion
In this study we showed that markers related with
endothelial injury including ADMA, OPG and TM were
significantly down-regulated in FMF patients who were
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